RESULT OF THE BUY-BACK OFFER

Udgivet den 14-02-2017  |  kl. 09:00  |  

Nasdaq Copenhagen
Nikolaj Plads 6
DK-1067 Copenhagen K   

Frederikssund, 14 February 2017
ANNOUNCEMENT NO. 3/2017

 

 

RESULT OF THE BUY-BACK OFFER

On 27 January 2017, Cemat A/S announced an offer to the shareholders to buy back the Company's own shares at a fixed price of DKK 0,352 per share.

At the end of the offer period, the Company has received 294,313,765 acceptances from shareholders representing 54.1% of the shares in the Company.

At the Company's general meeting held on 24 October 2016, the Board of Directors was authorised to buy back up to 337,993,060 shares, equivalent to around 62% of the shares in the Company.

As the number of shares tendered to the Company represents fewer shares than provided for under the authorisation, the number of shares purchased will not be reduced.

Immediately following this announcement, the Company will convene an annual general meeting to be held on 8 March 2017 for the adoption, among other things, of a capital reduction equivalent to the acceptances received. If the capital reduction is adopted, and if no significant claims are filed by creditors against the Company in the subsequent 4-week period (statutory notice), the Company is expected to complete and apply for registration of the capital reduction with the Danish Business Authority after expiry of the 4-week period on 11 April 2017.

Completion and settlement of the buy-back offer is expected to take place after the 4-week period on 11 April 2017.

Cemat A/S

Jens Borelli-Kjær

Chairman of the Board of Directors

 

This announcement has been issued in Danish and English. In case of any inconsistencies, the Danish version will prevail.

Unsubscribe announcements: investor@cemat.dk.

Vedhæftede filer:

03-17 Result of share buy-back offer.pdf

Udgivet af: NPinvestordk

Seneste nyheder

11:55 Obligationer/middag: Tysk gældsplan sender renten i højeste niveau siden juli 2024
11:49 Southwest Airlines bryder med årelang tradition: Slut med gratis baggage
11:37 Genmab: Oversigt over analytikernes ændringer efter Johnson & Johnson-melding
11:37 Aktier/middag: Nye klø til Genmab og Novo sender C25 i laveste niveau i fem uger
11:05 Ambu kan være på vej ind i et år med opkøb i milliardklassen
09:40 Obligationer/åbning: Renter stiger efter åbning til tysk investeringspakke
09:26 Aktier/åbning: Udsalg i Genmab og Novo fortsætter på ny blodrød dag for eliteindeks
09:14 Britiske byggeaktier er i hopla efter regeringsforslag
09:02 Genmab: Oversigt over analytikernes ændringer efter Johnson & Johnson-melding
08:42 Genmab bliver sænket til "hold" af Sydbank: Mangler kurstriggere på kort sigt
08:40 Råvarer: Oliepriserne stiger trods hav af bekymringer
08:22 Carlsberg sænkes til "hold" hos Jyske Bank efter stærk årsstart
08:18 Aktier/tendens: Rød dag i vente efter voldsom amerikansk nedtur - Novo og Genmab i fokus
08:03 Norsk storbank og Genmab: Fokus fremtid efter partners beslutning om Hexabody
07:53 Genmab får skåret kursmålet til 2300 kr. fra 2500 kr. af SEB efter kursklø
07:46 Tysklands De Grønne ser mulighed for finanspolitisk aftale inden ugen er omme
07:25 Trump kommer Elon Musk til undsætning: Vil købe en "splinterny Tesla"
07:17 Obligationer/tendens: Renter kan dykke efter ny Trump-panik og før jobtal
07:05 Danske Bank forventer blodrøde markeder efter største aktieudsalg i over to år
06:40 Asien: Frygt for at Trumps toldregime ender i recession dominerer